Lyell Immunopharma
Operator of a biotechnology company that develops cellular therapies to cure cancer.
HQ location
San Francisco, United States
Website
Launch date
Employees
Market cap
$132m
Enterprise value
($120m)
Share price
$8.84 LYEL
Recent deals
Authorizing premium user...